The FDA has initiated a pilot program (PDF) to help drug developers use complex innovative trial designs (CID). Sponsors accepted into the four-year pilot will…
A phase 1b trial has linked Xenon’s epilepsy candidate XEN1101 to statistically significant declines in measures of corticospinal and cortical excitability.…
Sensei Biotherapeutics named Ildiko Csiki, M.D., Ph.D., as its new chief medical officer. Csiki was previously VP of immuno-oncology clinical development at…
Gene-silencing specialist Sirnaomics has been cleared to start trials of its STP705 drug in bile duct cancer, its first oncology indication. The FDA has…
A member of Ukraine’s Electoral Commission revealed in an Aug. 7 Facebook post that they are working with NEM on a blockchain voting pilot. Oleksandr Stelmakh,…
The U.K. regulatory agency has detailed how it expects Brexit to affect its clinical trial regulations. Officials reiterated their intent for the U.K. to…